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Caroline Coisne, Ruth Lyck and Britta Engelhardt*Abstract
Background: The central nervous system (CNS) is an immunologically privileged site to which access for circulating
immune cells is tightly controlled by the endothelial blood–brain barrier (BBB) located in CNS microvessels. Under
physiological conditions immune cell migration across the BBB is low. However, in neuroinflammatory diseases such
as multiple sclerosis, many immune cells can cross the BBB and cause neurological symptoms. Extravasation of
circulating immune cells is a multi-step process that is regulated by the sequential interaction of different adhesion
and signaling molecules on the immune cells and on the endothelium. The specialized barrier characteristics of the
BBB, therefore, imply the existence of unique mechanisms for immune cell migration across the BBB.
Methods and design: An in vitro mouse BBB model maintaining physiological barrier characteristics in a flow
chamber and combined with high magnification live cell imaging, has been established. This model enables the
molecular mechanisms involved in the multi-step extravasation of T cells across the in vitro BBB, to be defined with
high-throughput analyses. Subsequently these mechanisms have been verified in vivo using a limited number of
experimental animals and a spinal cord window surgical technique. The window enables live observation of the
dynamic interaction between T cells and spinal cord microvessels under physiological and pathological conditions
using real time epifluorescence intravital imaging. These in vitro and in vivo live cell imaging methods have shown
that the BBB endothelium possesses unique and specialized mechanisms involved in the multi-step T cell migration
across this endothelial barrier under physiological flow. The initial T cell interaction with the endothelium is either
mediated by T cell capture or by T cell rolling. Arrest follows, and then T cells polarize and especially CD4+ T cells
crawl over long distances against the direction of flow to find the rare sites permissive for diapedesis through the
endothelium.
Discussion: The sequential use of in vitro and in vivo live cell imaging of T cells interacting with the BBB allows us
to delineate the kinetics and molecular determinants involved in multistep extravasation of encephalitogenic T cells
across the BBB.
Keywords: BBB, Immune cell trafficking, Live cell imaging, CD4 T cells, CD8 T cells, α4-integrinsBackground
The endothelial blood–brain barrier (BBB) protects the
central nervous system (CNS) from the constantly chan-
ging milieu in the vascular compartment by strictly con-
trolling the movement of molecules across its interface.
Thus, the BBB also establishes the border between the
immune system and the CNS. Immunosurveillance of
the CNS is achieved by allowing defined immune cells* Correspondence: bengel@tki.unibe.ch
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reproduction in any medium, provided the orthat hold the specific molecular keys to breach the BBB
and to enter the perivascular or leptomeningeal spaces
[1]. Mechanisms operating at the BBB are, therefore, in-
strumental in controlling immune cell migration into
the CNS. Whereas under physiological conditions the
number of immune cells crossing the BBB is low, during
CNS inflammation such as in multiple sclerosis (MS) or
its animal model, experimental autoimmune encephalo-
myelitis (EAE), a high number of immune cells enter the
CNS parenchyma causing inflammation, edema and de-
myelination [2]. Interestingly, even in the inflammatoryLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the CNS. This is exemplified by the fact that in MS and
EAE, myeloid cells and activated memory/effector T cells
preferentially cross the BBB. Thus, the kinetics and mo-
lecular interactions occurring between circulating im-
mune cells with the BBB are crucial in the pathogenesis
of EAE and MS.
In general, the multi-step recruitment of circulating
immune cells across the BBB is regulated by the sequen-
tial interaction of various adhesion or signaling mole-
cules on the leukocyte and on the endothelial cell
surfaces [3,4]. First, the interaction of adhesion mole-
cules from the selectin family with their cognate carbo-
hydrate ligands induces the rolling of the immune cell
along the endothelial cell surface at reduced velocity.
Next, chemokines displayed on the endothelial surface
bind to their respective G-protein coupled receptors
(GPCRs) on the leukocyte. This triggers the activation of
integrins on the immune cell surface via a conform-
ational change. Activated integrins bind to their endo-
thelial ligands of the immunoglobulin superfamily and
mediate the firm arrest of the immune cell on the endo-
thelial surface. The arrested immune cell polarizes and
starts crawling on the endothelial surface in search of a
site permissive for diapedesis. Successful migration of a
circulating immune cell across the endothelial cell wall,
therefore, requires the productive interaction of the im-
mune cell with the endothelial cells at each step of the
multi-step recruitment cascade [4]. Because the BBB
endothelium is highly specialized, unique dynamics and
molecular mechanisms are required for immune cell mi-
gration into the CNS.
Recently available sophisticated live cell imaging tech-
nologies combined with in vivo surgical window pre-
parations that overcome anatomical barriers and with
BBB models in flow chambers in vitro, have provided
powerful tools to study the cellular and molecular
mechanisms involved in immune cell migration under
physiological and pathological conditions. Combining
both techniques in the same laboratory ensures that the
number of animals used is minimized.
Advantages for experiments with in vitro BBB models
are high resolution imaging of the endothelium, easy
molecular and biochemical manipulations, less variability
and, last but not least, the possibility of a high through-
put of experimental conditions. Using in vitro BBB mod-
els established from different genetically-modified mice,
we defined the endothelial cell adhesion molecules me-
diating post-arrest T cell interactions and especially T
cell crawling against flow on the BBB [5]. As these find-
ings were confirmed by others in vivo [6], the in vitro
flow chamber approach has proved meaningful. Never-
theless, the limitations of this experimental approach are
the absence of blood viscosity and of pathophysiologicalflow conditions that occur in vivo. Thus verification of
in vitro findings in experimental animals in vivo is advis-
able to overcome limitations of the in vitro system.
Microscopic access to the CNS microcirculation for live
cell imaging has been achieved by the development of
sophisticated cranial and spinal cord window surgical
preparations [7,8]. A cranial window allows direct
visualization of the leptomeningeal and cortical grey
matter microcirculation whereas a spinal cord window
provides access to the leptomeningeal and spinal cord
white matter microcirculation [9,10]. We have pioneered
the use of epifluorescence intravital microscopy (IVM)
of the spinal cord white matter microvasculature in the
mouse to investigate in real time the molecular mechan-
isms involved in the multistep extravasation of CD4+
encephalitogenic T cells across the BBB in vivo [9,10].
These T cells induce experimental autoimmune enceph-
alomyelitis (EAE), an animal model for multiple sclerosis
(MS). Blocking T cell adhesion to the BBB by the func-
tional blocking of α4-integrin, inhibits the development
of EAE and is used as a therapeutic approach for the
treatment of MS [10,11].
Our current insight into the molecular mechanisms
involved in immune cell trafficking into the CNS relies
on studies performed with CD4+ T cells in EAE. Accu-
mulating evidence suggests, however, that CD8+ T cells
are also critically involved in the pathogenesis of MS. In-
deed, CD8+ T cells accumulate within active MS lesions,
often outnumbering CD4+ T cells [12]. Therefore, in this
study protocol we present our investigation on the
multi-step recruitment of CD8+ T cells across inflamed
spinal cord microvessels during EAE in vivo.
The aim here is to describe the in vitro and in vivo live
cell imaging approaches we have used to study the dy-
namics and molecular mechanisms involved in the
multi-step T cell migration across the inflamed BBB in
the context of the animal model of MS. We will high-
light the suitability of our in vitro imaging system of the
BBB under flow for investigating the molecular mechan-
isms involved in mediating shear-resistant T cell arrest
versus T cell crawling or T cell diapedesis across the
BBB. In addition we will describe experimental proce-
dures and results of studying the migration of CD8+ T
cells across the inflamed BBB by means of intravital
fluorescence videomicroscopy (IVM) of the spinal cord.
Methods and design
Live cell imaging of T cell recruitment across the BBB
in vitro
CD4+ T cells
In this study we used the encephalitogenic proteolipid
protein (PLP)aa139-151 specific CD4
+ Th1 effector/mem-
ory T cell line, SJL.PLP7, that has been described in de-
tail before [13]. T cells were used 3 days after the third
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a concentration of 0.5 × 106 cells per mL.
In vitro BBB models
The polyoma middle T oncogen immortalized mouse
brain endothelioma cell line (bEnd5) was described in
detail before [14,15]. The cells were used between pas-
sages 18 and 25 and cultured for at least 3 days on
laminin-coated surfaces (Roche, Basel, Switzerland). The
isolation and culture procedures of primary mouse brain
microvascular endothelial cells (pMBMECs) have also
been described in detail before [15-17]. These cells were
cultured on Matrigel-coated surfaces (BD Biosciences,
Allschwil, Switzerland) and used as primary cells (pas-
sage = 0) 5–7 days after plating. The yield of pMBMECs
from one mouse brain suffices to seed 3 wells with a sur-
face area of 0.3 cm2 each.
In vitro live cell imaging
All animal experiments for in vitro and in vivo experi-
ments were performed in accordance with the legislation
on animal welfare of the Swiss government and
approved by the Kanton Bern, Switzerland. To limit the
numbers of mice needed to be sacrificed for the isolation
of pMBMECs, we have developed a small custom-made
flow chamber (Figure 1). Growth area of pMBMECs isFigure 1 The in vitro flow chamber. The flow chamber is shown from th
panel A show the inlet and outlet tubes. Black arrows in panels B and C sh
panel B surrounds the inflow and the outflow and restricts medium flow to
panel C show the magnets embedded into the flow chamber to fix the ch
cloning ring shown with a diameter of 0.6 cm in image D restricts the surflimited to an area of 0.28 cm2 by a custom-made silicon
ring with a diameter of 0.6 cm (Figure 1D). Endothelial
cells are stimulated with recombinant murine tumor
necrosis factor alpha (TNF-α 10 ng/mL, PromoKine,
Vitaris) for 16 to 20 h prior to the experiment. For
optimal imaging quality, the culture dish has a hydro-
philic foil-like base and excellent optical properties
(μ-dish35 mm-low, ibidi Vitaris, Baar, Switzerland). To allow
for differential interference contrast (DIC) imaging, which
relies on glass or a specific DIC-compatible plastic, the
field of view (FOV) is covered with glass (Figures 1B
and C). The flow channel is formed from a central rect-
angular cut-out in a removable silicon mat. The height
of the flow channel is defined by the thickness of the
silicon mat and the mat is fitted onto the lower surface
of the flow chamber which has inlet and outlet tubes
(Figure 1B). Stable mounting of the chamber on the
endothelial monolayer is achieved through two integrated
magnets (Figure 1C) exerting positive magnetic pull to-
wards a metal ring, which is placed onto the outer surface
of the base of the culture dish. After the silicon ring is
removed from the culture dish, the inlet tubing of the flow
chamber is filled with migration assay medium (MAM)
(5% calf serum, 10 mM Hepes in DMEM with glutamine)
and the flow chamber is placed on the endothelial cells.
Flow is applied by connecting the outlet tubing to ae side (A), from the base (B) and from the top (C). White arrows in
ow the field of view. A rectangle within the thin silicon mat visible in
a small chamber 2 mm wide and 0.25 mm high. White arrows in
amber via a metal ring opposed on the base of the culture dish. The
ace area of brain endothelial cells to 0.28 cm2. Scale is in cm.
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vard Apparatus, Holliston, MA, USA). The flow rate is
calculated according to the formula:
τ dyne=cm2
  ¼ 3  μ  Qð Þ= 2  a2  bð Þ
[18] with μ (dynamic viscosity) = 0.083 dyne*sec/cm2
(DMEM, 5% calf serum at 37°C [19]);
Q (flow) = variable value to be controlled by the pump
in cm3/sec;
a. (half height of chamber) = 0.125 mm;
b. (width of chamber) = 2 mm.
Aspiration of T cells from a reservoir via the inlet
tubing is performed at 1.5 dyne/cm2 until the T cells
appear in the field of view. T cell interaction with
the endothelial surface occurs during the accumula-
tion phase, which is started by a reduction of flow
to 0.2 dyne/cm2. This allows settling of the T cells
on the endothelial surface, which due to the size of the
flow chamber only occurs under reduced shear conditions.
The accumulation phase is terminated after 4 min as illu-
strated in Movie 1 (12 images/min, Additional file 1)
and Movie 2 (3 images/min, Additional file 2); or
after 8 min in Movie 3 (3 images/min, Additional file 3)
by increasing the flow to 1.5 dyne/cm2, thus mimick-
ing more closely physiological flow conditions within
CNS post-capillary venules. Image recording in time-
lapse mode is started at the beginning of the accumu-
lation phase and continued for 15 to 30 min.Microscopic equipment for computer-controlled in vitro live
cell imaging
For microscopic imaging, the assembled flow chamber
is placed on the stage of an inverted microscope
(AxioObserver.Z1, Carl Zeiss, Feldbach, Switzerland)
equipped with a temperature-controlled chamber (37°C).
Image acquisition is performed by computer control
using the AxioVision 4 software (Carl Zeiss) at a rate of
3 or 12 images per min and with a 10-fold (Objective
EC “Plan-Neofluar” 10x/0,3 Ph1 M27) (Additional file 1:
Movie 1), 20-fold (Objective LD “Plan-Neofluar” 20×/0,4
Korr Ph2 M27) (Additional file 3: Movie 3) or 40-fold
(Objective LD “Plan-Neofluar” 40×/0,6 Korr Ph2
M27) (Additional file 2: Movie 2) magnification using
a monochrome CCD camera (AxioCam MRmRev,
Carl Zeiss). The size of the image (FOV) acquired
with the camera depends on the microscope magnifi-
cation and is 653 μm × 869 μm for 10-fold magnifi-
cation, 438 μm × 329 μm for 20-fold and 215 μm ×
162 μm for 40-fold.Analysis of dynamic T cell interactions with the brain
endothelium: T cell arrest and migratory phenotype
The dynamic interaction of T cells with the endothelium
is evaluated by assigning a migratory phenotype to each
T cell. To this end, each arrested T cell is assigned a digit
shortly after the accumulation phase (as an example: see
Additional file 3: Movie 3, at time point 8 min 20 sec).
The behavior of each individual T cell is analyzed
throughout the complete movie and then accordingly
assigned to one category. T cells that continuously crawl
are categorized as “Crawling”. T cells that diapedese after
having crawled to the site of diapedesis are categorized
as “Crawling/Diapedesis”, T cells that detach from the
endothelium are categorized as “Detachment”. T cells
that do not crawl are categorized as “Stationary”
(Figure 2A). When dynamic T cell behavior with
pMBMECs is imaged at higher resolution, additional cat-
egories can be defined. For example, we added a cat-
egory “Crawling/partial diapedesis” describing T cells
which crawled and started but did not completely dia-
pedese during the observation time (Figure 2B). Arrested
T cells that enter or leave the FOV during the recording
time are excluded from the evaluation. The categories
are then expressed as % of arrested T cells. To determine
their crawling velocities and crawling distances, all T
cells categorized as “Crawling” or “Crawling/Diapedesis”
are tracked manually, using ImageJ software (National
Institute of Health, Bethesda, MD, USA) using the man-
ual tracking and chemotaxis plugins.
In vitro live cell imaging allows a detailed analysis of the
dynamic behaviour of T cells adherent on the surface of
BBB endothelial cells
Different in vitro BBB models are available for studying
the cellular and molecular mechanisms of T cell migra-
tion across the BBB. We compared the migration of
encephalitogenic T cells across the polyoma middle T
oncogene-immortalized brain endothelial cell line,
bEnd5, to primary mouse brain microvascular endothe-
lial cells (pMBMECs) in a static two chamber-based
assay as described by Röhnelt and colleagues in 1997
[20]. Although T cell adhesion to both in vitro BBB mod-
els was comparable, T cell diapedesis across bEnd5 was
4.5 fold more efficient when compared to migration
across pMBMECs within 6 h [15]. This suggests that
pMBMECs, but less so bEnd5, provide a strict barrier
for T cell diapedesis as observed in vivo. Since the bar-
rier characteristics of pMBMECs more closely resemble
the integrity of the BBB in vivo, it is likely that barrier
characteristics influence the cellular and molecular path-
ways of T cell migration across the BBB in vitro. There-
fore we continued to study the molecular mechanisms
involved in this process by employing pMBMECs
derived from mice deficient for intercellular cell
Figure 2 The migratory phenotype of T cells. Representative experiments of T cell interactions with TNF-α stimulated pMBMECs in vitro under
flow conditions during a period of 15 minutes (2A) or for 3 different time periods of 10, 15 or 20 minutes (2B). The behavior of each arrested T
cell was analyzed by eye in an offline analysis of the time-lapse videos and assigned to one category and expressed in percentage of initially
arrested T cells. Arrested T cells that crawled into or out of the FOV during the recording time were excluded from the analysis. “Crawling”: T cells
that polarized and crawled at least two T cell diameter distance but did not diapedese across the endothelium. “Crawling/partial diapedesis”: T
cells that polarized, crawled and started but did not complete diapedesis during the indicated time period. “Crawling/Diapedesis”: T cells that
polarized and crawled until they finally crossed the endothelial cell monolayer. “Detachment”: T cells that detached during the evaluation period.
“Stationary”: T cells that did not polarize and remained stationary. 2A: Experiment imaged with 10x objective. A total of 64 cells were categorized.
2B: Experiment imaged with 20x objective. A total of 37 cells were categorized.
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ICAM-2 dKO) and pMBMECs derived from wild type
(wt) mice. There was a dramatic reduction of T cell dia-
pedesis across either ICAM-1 KO or ICAM-1/ICAM-2
dKO pMBMECs when compared to wt pMBMECs [5].
A disadvantage of the static two-chamber setup is that it
does not discriminate between the involvement of endo-
thelial ICAM-1 in T cell adhesion to the BBB versus T
cell diapedesis across the BBB. Therefore, we extended
our experimental portfolio to an in vitro live cell imaging
method that enables visualization of the multistep T cell
extravasation across in vitro BBB models under condi-
tions of physiological flow.
Although flow chambers are commercially available,
we developed a small-sized flow chamber (Figure 1) suit-
able for a small area of cultured brain endothelial cells
and for the low number of pMBMECs obtained from
each isolation procedure. Using this flow chamber we
visualized the dynamic behavior of encephalitogenic
CD4+ T cells while adherent on the apical surface of
pMBMECs. Whereas many T cells arrest on the surface
under low shear stress, non-bound T cells are readily
washed away when the shear stress is increased to
physiological conditions. However, most of the T cells
which resist detachment after increase of shear remain
adherent throughout the remaining observation period.
These T cells polarize within seconds and start crawling
on the endothelial surface. Crawling occurs either con-
tinuously throughout the complete recording period, or
is followed by diapedesis across the endothelialmonolayer (Additional file 1: Movie 1, Additional file 2:
Movie 2). The velocity of crawling on TNFα-stimulated
pMBMECs is about 4 μm/min, and preferentially against
the direction of flow [15]. Evaluation of the dynamic be-
havior of T cells while adherent to the endothelial sur-
face is qualitatively and quantitatively analyzed such that
all arrested T cells are counted and set to 100% and the
4 categories “Crawling”, “Crawling/Diapedesis”, “Detach-
ment” and “Stationary” are expressed as fractions of
initially-arrested T cells. Figure 2A shows one represen-
tative experiment using encephalitogenic CD4+ Th1 T
cells and TNFα-stimulated pMBMECs over an observa-
tion period of 15 min. In this experiment, 64% of T cells
continuously crawled, 27% crawled and diapedesed, 1%
detached from the endothelium and 7% remained sta-
tionary without crawling during the observation period.
To determine how recording time affects the dy-
namic interaction of T cells with pMBMECs under
flow in vitro, we analyzed the migratory phenotype
at three time points: 10, 15 and 20 min (Movie 3
shows 20 min, Additional file 3). As shown in
Figure 2B, 10 min recording resulted in 62% con-
tinuously crawling T cells, whereas 20 min recording
reduced this to 43%. This reduction was offset by an
increase in the fraction of T cells that completely
diapedesed across the monolayer from 11% at
10 min to 43% after 20 min. Thus, recording times
must be carefully chosen and strictly maintained
during an experimental series to allow for compar-
able data analysis.
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compared T cell interactions on pMBMECs with those
on bEnd5 cultures [15]. This showed that T cells need to
crawl long distances on pMBMECs, preferentially
against the direction of the flow, to find sites permissive
for diapedesis. However, they readily cross a monolayer
of bEnd5 cultures [5]. This supports the suggestion that
the integrity of in vitro BBB models impacts on T cell
migration across the BBB. T cell crawling against the dir-
ection of the blood flow is a unique behavior of ence-
phalitogenic T cells when crossing inflamed spinal cord
microvessels during the onset of EAE in vivo [6]. Hence,
our in vitro live cell imaging setup can be used to study
the cellular and molecular mechanisms involved in T cell
migration into the CNS. To this end we analyzed the
role of endothelial ICAM-1 and ICAM-2 in this process.
Using pMBMECs from wt and ICAM-1/ICAM-2 dKO
mice, we found that whereas T cell arrest on pMBMECs
is mediated by endothelial ICAM-1 and VCAM-1, endo-
thelial ICAM-1 and ICAM-2 are essential for T cell
polarization and crawling on brain endothelium under
flow in vitro [5].
Combining in vitro pMBMEC preparations from
genetically-modified mice with live cell imaging under
flow, can identify cellular and molecular mechanisms
involved in the multi-step T cell migration into the CNS
in the context of neuroinflammatory diseases. Observa-
tions made in vitro [5] can be verified in vivo [6]. This
experimental setup can provide valuable insights into
the molecular mechanisms directing transcellular or
paracellular diapedesis of T cells across the BBB. It can
also be used to study the multi-step migration of other
immune cell subsets such as neutrophils, monocytes or
CD8+ T cells across the BBB.
Live cell imaging of immune cell recruitment across the
BBB in vivo: Intravital fluorescence videomicroscopy (IVM)
Recipient mice and induction of active experimental
autoimmune encephalomyelitis
C57BL/6 female mice, 8–12 weeks old, with an approxi-
mate body weight of 20 g were used in accordance with
the local government legislation on animal welfare and
experimentation. EAE was induced by sub-cutaneous
immunization with 200 μg of myelin oligodendrocyte
glycoprotein peptide (MOGaa35-55) in incomplete
Freund’s adjuvant (IFA; Santa Cruz, USA) supplemented
with 4 mg/mL nonviable, desiccated Mycobacterium tu-
berculosis (H37RA; Difco Laboratories, Detroit, USA)
exactly as described before [10]. On day 1 and 3 post-
immunization, 300 ng pertussis toxin from Bordetella
pertussis (LuBioScience, Lucerne, Switzerland) per
mouse were injected intra-peritoneally. Assessment of
clinical disease score and weight of mice with active
EAE was evaluated twice a day using a four-pointscoring system as follows: 0, healthy; 0.5, limp tail; 1,
hind leg parapesis; 2, hind leg paraplegia; and 3, hind leg
paraplegia and incontinence. Mice suffering from clinical
scores 0.5 (limp tail) to 2 (hind leg paraplegia), with a
body weight of at least 15 g were used as recipients for
IVM experiments.CD8+ T cell isolation
CD8+ T cells were prepared from T cell receptor (TCR)
transgenic C57BL/6 mice in which CD8+ T cells
recognize the immunodominant MHC class I (H-2Kb)
epitope of chicken ovalbumin (SIINFEKL). Spleen and
lymph nodes were collected from OT-I mice, cut in
pieces and digested 30 min at 37°C in 5 mL Roswell park
memorial institute (RPMI) medium supplemented with
DNAse I (0.2 mg/mL; Boehringer Manheim, Germany)
and liberase CI (0.4 mg/mL; Roche Applied Sciences,
Switzerland). Afterwards, digested organs were crushed
between 2 sterile glass slides. The resulting cell suspen-
sion was then filtered through a sterile 100 μm-nylon
mesh and centrifuged for 10 min at 250 g. Cells, 7.5 ×
106 per 60 mm diameter petri dish, were plated in cul-
ture medium (RPMI-1640 supplemented with 10% FBS,
2 mM L-glutamine, 1 mM sodium pyruvate, 100 U peni-
cillin-streptomycin, 0.05 mM 2-mercaptoethanol) and
50 μg SIINFEKL peptide (OVA- peptide257-263; Peptides
international, Louisville, KY, USA) were added. Cell suspen-
sions were incubated at 37°C in 7% CO2 for 5 days. On day
4, IL-2 (5 ng/mL; R&D Systems, Abingdon, UK) was added
overnight in each dish. Then freshly-activated live CD8+
OT-I T cell blasts were isolated by Nycoprep 1.077 A
(Axis-Shield, Dundee, UK) density gradient centrifugation.Fluorescent labeling of T cells
After 3 to 4 days in culture, OT-I T cells were labeled
with 2.5 μM Cell Tracker™ green (CMFDA; Molecular
probe, Oregon, USA) in culture medium (RPMI-1640
supplemented with 10% FBS, 2 mM L-glutamine, 1 mM
sodium pyruvate, 100 U penicillin-streptomycin, 0.05 mM
2-mercaptoethanol) for 45 min at 37°C in the dark. Cells
were subsequently washed by adding fresh complete wash
buffer (HBSS supplemented with 5% FCS and 25 mM
HEPES) and centrifuged 10 min at 250 g. Excess dye was
removed from the T cells by plating 5 × 106 fluorescently
labeled cells in a 100 mm petri dish in10 mL culture
medium for 30 min at 37°C. Cell tracker™ green-labeled T
cells were directly used for IVM or stored in complete
medium at 37°C and 7% CO2 up to 6 h before use. In par-
allel with the spinal cord window microsurgery, 5-6 × 106
of Cell trackerTM green-labeled immune cells were col-
lected and centrifuged for 10 min at 250 g. The cell pellet
was then re-suspended in a small volume of NaCl 0.9%
isotonic solution. Cells were counted and the volume of
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suspension of 4 × 106 cells in 300 μL. The T cell suspen-
sion was filled into a 1 mL-syringe ready for injection into
the mouse circulation.
Microsurgical preparation of the spinal cord window
Mice were anaesthetized by subcutaneous injection of keta-
mine-hydrochloride/xylazine (100 mg/kg and 5.6 mg/kg re-
spectively), followed by a subcutaneous injection of
acepromazine (1.5 mg/mL). Throughout the experiment,
anaesthesia of the animals was carefully monitored and, if
necessary, a half dose was injected to maintain deep anaes-
thesia. During the surgical procedure and IVM experiment,
body temperature was maintained by placing the animal on
a thermo-controlled heating pad to prevent hypothermia
which would influence blood supply to the brain and the
hemodynamic parameters of the circulation.
Under the stereomicroscope, the right common ca-
rotid artery was catheterized in the direction of the aor-
tic arch for systemic infusion of fluorescently-labeled T
cells and 1% tetramethylrhodamine isothiocyanate
(TRITC)-conjugated Dextran used as a plasma marker.
Afterwards, the animal was turned to the prone position
and the head was placed in a stereotactic holder. The
midline skin of the neck was incised for 2–3 cm and the
paravertebral musculature was dissected from the cer-
vical spine processes and retracted laterally by the use of
4–0 threads, exposing the vertebral lamina. A laminec-
tomy was then carried out from C7 to C2 and the dura
mater over the spinal cord was removed avoiding anyFigure 3 Experimental setup of the intravital fluorescence videomicro
placed under an epifluorescence microscope, coupled with a mercury lamp
camera that includes an image processor, associated videotimer, a digital v
analysis, real time videos were recorded using a digital videocassette.A: Eva
post capillary venules (20–60 μm diameter) of the spinal cord microvascula
fractions (%) of OT-I CD8+ T cells with the post capillary venules (20–60 μm
afflicted with MOG35-55-induced EAE.trauma to the microvasculature and underlying spinal
cord parenchyma. The preparation was then covered
with a transparent plastic membrane to prevent dehy-
dration and access of ambient O2 to the exposed tissue.
Intravital fluorescence videomicroscopy (IVM)
The animal remaining within the stereotactic head
holder was transferred to the stage of the inverted fluor-
escence microscope (Figure 3). IVM was performed by
epi-illumination techniques using a custom-made
Mikron IVM500 microscope (Mikron Instruments, San
Marcos, CA, USA) coupled with a 50 W mercury lamp
(HBO 50 microscope illuminator, Zeiss, Switzerland)
attached to combined blue (exciter 455DF70, dichroic
515DRLP, and emitter 515ALP) and green (exciter
525DF45, dichroic 560DRLP, and emitter 565ALP) filter
blocks. The microscope is connected to a low-
light-imaging silicon-intensified target (SIT) camera
(Dage-MTI Inc., Michigan city, IN, USA) coupled with a
TrinitronW color video monitor (Sony, Switzerland) and
a videotimer (MicroImage Video Systems, Boyertown,
USA). For later real time off-line analysis, images
were recorded using a digital videocassette recorder
(VCR) (Figure 3). Observations were made using a
× 4, ×10 and × 20 long-distance objectives (Zeiss,
Switzerland), resulting in × 80, ×215 and × 440 mag-
nifications, respectively.
First, the microvasculature of the spinal cord was
observed within the green light epi-illumination (×4 ob-
jective) by intra-carotid injection of the pre-warmedscopy workstation. The animal preparation under anesthesia is
connected to a low-light-imaging silicon-intensified target (SIT)
ideocassette recorder (VCR) and a video monitor. For later off-line
luation of the initial contact fraction (%) of OT-I CD8+ T cells with the
ture of mice with EAE B: Shows the evaluation of capture and rolling
diameter) of the spinal cord white matter microvasculature of mice
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(1%, MW= 155,000; Sigma-Aldrich, Switzerland) in 0.9%
isotonic NaCl. The spinal cord is divided into two parts
by the middle dorsal vein, delineating a top and bottom
half of the entire window. On both sides, capillaries and
post-capillary venules draining into the middle dorsal
vein can readily be visualized. Between 4 and 6 stepwise
FOVs per animal could be delineated on each side of the
spinal cord window (10× objective). Using the blue light
epi-illumination (10× objective), 4 × 106 Cell Tracker™
green-labeled activated OT-I CD8+ T cells were slowly
infused in 3 aliquots of 100 μL and were directly
observed within the spinal cord microcirculation where
they initiated contact with the inflamed spinal cord
white matter endothelium. For each injection of 100μL,
a different FOV was recorded for a minimum of one mi-
nute in order to observe sufficient CD8+ T cells interact-
ing with the endothelium for later off-line analysis. After
the infusion of each aliquot, the arterial catheter was
flushed with 60 to 80 μL pre-warmed isotonic 0.9% NaCl
to guarantee all cells were injected. At different time
points after cell injection (10 min, 30 min and 1 h), all
fields of view of the spinal cord window were sequen-
tially scanned and recorded for further evaluation of the
number of permanently adhering fluorescent CD8+ T
cells. At the end of the recording period, animals were
sacrificed.Targeting of cell surface adhesion molecules on BBB
endothelium
In order to evaluate the involvement of a specific adhe-
sion molecule or its ligand in T cell trafficking across the
spinal cord microvasculature endothelium in vivo, acti-
vated T cells or the BBB endothelium were pre-treated
with function-blocking antibodies. To this end, 4 × 106
Cell TrackerTM green-labeled CD8+ T cell blasts in 300
μL isotonic 0.9% NaCl solution were incubated with
120 μg blocking monoclonal antibody (mAb) directed
against a specific adhesion molecule for 20 min prior to
their injection into the bloodstream. The use of
antibodies in vivo requires endotoxin-free antibody
preparations and appropriate isotype controls. Using
non-blocking antibodies from the same isotype as the
blocking mAb, ensures against nonspecific side effects
mediated by the Fc portions of the immunoglobulins.
Control antibodies specific for molecules expressed on
the surface of circulating immune cells or on the BBB
endothelium, which do not interfere with T cell trafficking
are preferable over non-binding irrelevant isotype control
antibodies remaining in the circulation. In this study, rat-
anti-mouse α4-integrin (PS/2), rat anti-mouse α4β7 integ-
rin (DATK-32), and rat anti-mouse β7 integrin (Fib 504)
were used and obtained from serum-free hybridomaculture supernatants. Endotoxin levels, determined using
Endosafe test (Charles River Laboratories, Sulzfeld,
Germany), were below detection level. Endotoxin-free rat
IgG2b was used as isotype control.
Quantitative analysis of the IVM data
Initial contact of circulating T cells within post-
capillary venules of the spinal cord white matter in
mice with active EAE. From each observed post-
capillary venule (diameter = 20–60 μm), the percentage
of T cells initiating contact with the BBB endothelium
as observed by IVM was determined at the time point
of cell injection. The total number of T cells was
injected in 3 aliquots and 1 FOV was visualized for
each injection. Thus the initial interaction of circulating
T cells could be analyzed in a substantial number of
spinal cord post-capillary venules per animal. The num-
ber of T cells (> 10 cells/min) rolling along the vessel
wall or captured (abruptly arrested without any prelim-
inary rolling step) was counted per post-capillary ven-
ule, and related to the total number of fluorescent
circulating T cells (total cellular flux, TFx) passing
through the vessel during one minute. The rolling frac-
tion (RF) or the capture fraction (CF) was calculated
and the total initial contact fraction (ICF) calculated
from the sum of RF and CF (summarized in Table 1).
Both rolling and capture events were confirmed by cal-
culating the critical velocity in μm.s -1 (Vcrit). Vcrit is the
velocity of an idealized cell traveling along, but not
interacting with the vessel wall. It can be derived from
the parabolic velocity profile of the circulation in the
microvessel, as follows:
Vcrit ¼ Vblood  DL=DVð Þ  2 DL=DVð Þ½ 
in which DL and DV correspond to the diameter (mm)
of the leukocyte and the diameter of the post-capillary
venule, respectively, and Vblood corresponds to the
mean blood flow velocity (summarized in Table 1). Any
leukocyte circulating below Vcrit was considered as an
interacting cell rolling along the vessel wall, whereas
any cell traveling above Vcrit was defined as a non-
interacting cell [21,22]. Statistics using Mann–Whitney
U-Test to compare 2 variables and Kruskall-Wallis to
compare more than 2 variables were then performed.
Firm adhesion of T cells within inflamed spinal cord
post-capillary during EAE. Firmly adherent T cells
were identified as fluorescent cells that stick to the
vessel wall without moving or detaching. Trapped T cells
within the capillary network, were defined as cells that
do not move and clearly obstruct the capillary lumen,
resulting in blood flow stasis. The permanent adhesion
of T cells at 10 min, 30 min and 1 h after infusion was
Table 1 Parameters analyzed by intravital microscopy (modified from [22])
Parameter Unit Formula
Total Cellular Flux (TFx) min-1 Number of T cells that pass through a vessel during a given observation period
Initial Contact Flux (ICFx) min-1 Number of immune cells that interact, either by rolling or getting captured to, with the vessel wall
during an observation period
Initial Contact Fraction (ICF) % ICF = ICFx/TFx × 100
Rolling Flux (RFx) min-1 Number of immune cells that roll along the vessel wall during an observation period
Rolling Fraction (RF) % RF = RFx/TFx × 100
Capture Flux (CFx) min-1 Number of immune cells that are captured to the vessel wall during an observation period
Capture Fraction (CF) % CF = CFx/TFx × 100
Firm Adhesion/Field Of
View (FOV)
none Number of firmly adherent T cells per one field of view (FOV) within the spinal cord window
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per field of view (FOV) observed with the × 10 objective
[23]. As 4–6 FOVs could be identified on each side of
the spinal cord window, all calculations of firmly ad-
herent T cells per FOV from different mice were
grouped to calculate the mean +/− standard deviations
for each animal. Statistics using Mann–Whitney U-Test to
compare 2 variables and Kruskall-Wallis to compare more
than 2 variables are then performed.
Contribution of a4β1-versus a4β7-integrin in the interaction
of CD8+ T cells with the inflamed BBB in vivo
Blocking T cell entry into the CNS with the humanized
anti-α4 integrin antibody, natalizumab, has proved effi-
cient in the treatment of relapsing-remitting multiple
sclerosis [11]. However, natalizumab is associated with
an increased risk for developing progressive multifocal
leukoencephalopathy, a fatal disease of the CNS caused
by JC virus infection of oligodendrocytes [24]. This ob-
servation suggests that therapeutic targeting of α4-integ-
rins may ultimately impair immunosurveillance of the
CNS by cytotoxic CD8+ T cells.
To investigate if CD8+ T cells use molecular mechan-
isms similar to CD4+ T cells to migrate across the BBB
in vivo, we studied the interaction of CD8+ OT-I T cells
with the inflamed spinal cord white matter microvascu-
lature in C57BL/6 mice during EAE to determine if
CD8+ T cells also use α4β1- but not α4β7-integrins to
adhere to the inflamed BBB as previously shown for
CD4+ T cells [25,26]. The purity of CD8+ OT-I T cell
preparations was confirmed by FACS staining, which
demonstrated that 95% of the OT-I T cell blasts stained
positive for CD8, an acceptable purity for performing
IVM (data not shown). Prior to their infusion into the
circulation of the recipient mouse, fluorescently-labeled
OT-I T cell blasts were pre-treated with integrin block-
ing or control antibodies (480 μg Ab/ 4 × 106 OT-I T
cells/ 400 μl with the exception of DATK-32, which
was used at 960 μg/ 4 x 106 OT-I T cells/ 400 μl due
to its low affinity). Following the visualization of thespinal cord vascular system by injection of TRITC-dex-
tran, OT-I T cells were systemically infused via the
right carotid artery and their interaction with the spinal
cord microvasculature observed and recorded in real
time (Figure 3, Additional file 4: Movie 4 and Additional
file 5: Movie 5). The initial contact (rolling and capture)
and firm adhesion of OT-I T cells to the spinal cord
vasculature were evaluated by off-line frame-by-frame
video analysis. The following conditions were studied:
rat IgG2b used as a control antibody, PS/2 (anti-α4
subunit), DATK-32 (anti-α4β7 integrin) and Fib 504
(anti-β7 subunit). Upon systemic infusion, activated
OT-I T cells were observed to pass through the spinal
cord microvessels and initiate contact with the inflamed
CNS endothelium (Additional file 4: Movie 4). Contact
initiation was mediated either by OT-I T cells rolling with
reduced velocity along the vascular wall or to a lesser
degree by capture, i.e. an abrupt arrest of the CD8+ T
cells on the vascular wall. Pre-treatment of OT-I T cells
with either isotype control mAb or blocking antibodies
against α4-, β7- or α4β7- integrins showed no effect on
their intrinsic abilities to initiate contact with the
inflamed BBB endothelium (Figure 4A), either by rolling
or capture to the spinal cord microvasculature wall
(Figure 4B). To determine whether the initial contact of
OT-I T cells resulted in arrest and firm adhesion to the
inflamed microvasculature (Additional file 5: Movie 5),
the number of OT-I T cells permanently adhering within
microvessels at different time points (10 min, 30 min and
1 h) after T cell infusion for each tested condition was
measured (Figure 5). Ten minutes after infusion, the inhib-
ition of α4-integrins resulted in a 50% reduction of the firm
adhesion of OT-I T cells to the microvasculature when
compared to IgG2b isotype control treatment, whereas
blocking of α4β7- or β7-integrins only reduced the adhe-
sion of OT-I T cells by 30%. These data suggested that both
α4-integrins mediate OT-I adhesion to the inflamed spinal
cord microvasculature. Interestingly, the involvement of
α4-integrins in mediating OT-I T cell adhesion to the
inflamed BBB was only transient, as at the later times
Figure 4 Quantification of OT-I CD8+ T cell interactions with the spinal cord microvasculature in vivo. A: Evaluation of the initial contact
fraction (%) of OT-I CD8+ T cells with the post capillary venules (20–60 μm diameter) of the spinal cord microvasculature of mice with EAE. Each
dot represents 1 venule. All values show the median with the interquartile range of n = 22 analyzed post-capillary venules from 3 mice for rat
IgG2b condition, n = 18 analyzed post-capillary venules from 5 mice for anti- α4β7 condition, n = 18 analyzed post-capillary venules from 6 mice
for anti- β7 condition and n = 23 analyzed post-capillary venules from 4 mice for anti-α4 condition. B: Shows the evaluation of capture and
rolling fractions (%) of OT-I CD8+ T cells with the post capillary venules (20–60 μm diameter) of the spinal cord white matter microvasculature of
mice afflicted with MOG35-55-induced EAE. N = 22 analyzed post-capillary venules from 3 mice for rat IgG2b condition, n = 18 analyzed post-
capillary venules from 5 mice for anti- α4β7 condition, n = 18 analyzed post-capillary venules from 6 mice for anti-β7 condition and n = 23
analyzed post-capillary venules from 4 mice for anti-α4 condition. Statistical significance was determined by the Mann–Whitney U-Test.
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presence of α4-integrin blocking antibodies. At these times
there were lower numbers of OT-I cells firmly adhering
under control conditions. These results suggest that during
EAE, activated CD8+ T cells interact with the inflamed
BBB. In contrast to CD4+ T cell blasts, CD8+ T cells are
able to initiate contact and to maintain stable adhesion to
the inflamed BBB independent of α4-integrins [10,25].Figure 5 Quantification of OT-I CD8+ T cell firm adhesion to the post
mice during EAE. Permanently adhering OT-I T cells were counted 10 min
number of adherent OT-I T cells/field of view (FOV). The numbers of mice
6 for anti-α4β7, n = 6 for anti-β7 and n = 8 for anti-α4. At t = 30, n = 8 for
At time t = 1 h, the number of mice was n = 7 for rat IgG2b, n = 5 for ant
presented as mean values +/− standard deviation (SD). Mann–Whitney U-T
indicate significant differences (*P < 0.05, and ***P < 0.005), n.s.: not significStatistical analysis
All statistical analysis were performed using the Graph-
Pad Prism software (version 5.00, GraphPad Software,
CA, USA). Data are presented as mean values +/− stand-
ard deviation (SD). Mann–Whitney U-Tests were used
for comparisons between different data sets. Asterisks
indicate significant differences (*P < 0.05, **P < 0.01
and ***P < 0.005).capillary venules of the spinal cord microvasculature of C57BL/6
, 30 min and 1 hour after cell infusion. Each dot represents the
analyzed at t = 10 min for each condition was n = 8 for rat IgG2b, n =
rat IgG2b, n = 6 for anti-α4β7, n = 6 for anti-β7 and n = 4 for anti-α4.
i-α4β7, n = 5 mice for anti-β7 and n = 5 for anti-α4. Data are
est was used for comparisons between different data sets. Asterisks
ant.
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Investigation of the cellular and molecular mechanisms
of T cell migration across the BBB in the context of MS
has become possible with the development of live cell
imaging approaches that record the dynamic interaction
with the BBB during EAE. Using a flow chamber setup
for brain endothelial cell cultures or a microsurgical
window for observation of the spinal cord microvascula-
ture, has enabled the study of dynamic T cell interac-
tions with the BBB under physiological flow both
in vitro and in vivo.
The in vitro flow chamber with time-lapse live cell im-
aging has been used to study the post-arrest dynamic be-
havior of encephalitogenic CD4+ T cells on the inflamed
BBB under flow conditions. The cellular and molecular
events underlying the multi-step T cell extravasation
across the inflamed BBB in vitro have been studied and
the functions of different endothelial adhesion molecules
in mediating CD4+ T cell arrest, versus polarization and
crawling were delineated. These experiments underline
the active role of the BBB endothelium in controlling T
cell extravasation during immunosurveillance and in-
flammation. Results in vitro have been confirmed in vivo
by two recent studies investigating T cell extravasation
across the spinal cord microvasculature during EAE by
two-photon IVM [6,27], which showed that T cells crawl
long distances against the direction of the blood-flow on
the spinal cord endothelial surface to find a site permis-
sive for diapedesis using the molecular mechanism
found in our studies [5].
Using high resolution in vitro imaging, we are studying
the cellular and molecular mechanisms involved in T cell
diapedesis across the BBB under physiological flow to
determine if T cells breach the BBB via a transcellular or
paracellular route. With pMBMEC preparations of gene-
targeted mice and fluorescent-tagged adhesion and junc-
tional molecules, it will be possible to distinguish the
molecular events in these processes.
It is important to note that although the flow chamber
set-up described here is suitable to study the entire
multi-step T cell extravasation across the BBB, the com-
bination with time lapse imaging does not allow fast
movements as observed during T cell tethering or rolling
on the BBB to be recorded. Whereas T cell rolling along
the BBB occurs with velocities of several hundreds of
μm per second, T cell polarization and crawling events
as described here are much slower and occur at veloci-
ties of several μm per minute. Thus investigation of T
cell tethering and rolling using such an in vitro flow
chamber requires real time imaging at 20 images per
second, minimum, or even more than 30 images per
second.
In contrast, the IVM real time imaging method
described here is optimal to study the initial interaction(rolling/capture), the arrest and the firm adhesion of T
cells within the spinal cord microvasculature under
physiological flow conditions in vivo. Observation times
of one minute suffice to study the initial T cell inter-
action with the spinal cord microvasculature in vivo and
therefore avoid phototoxic effects on the vasculature.
Similarly, one minute video sequences of the different
FOVs at defined time points after systemic T cell infu-
sion will enable study of T cell adhesion to the BBB
in vivo over extended times. Due to the short observa-
tion times necessary, we have previously used this im-
aging approach to successfully study the interaction of
human T cells with the spinal cord microvasculature
during EAE in vivo in immunocompetent mice, since
human integrins engage with mouse endothelial ligands
comparable to the human endothelial ligands [10]. In
this xenogeneic approach we showed that the anti-α4-in-
tegrin antibody natalizumab, used for the treatment of
relapsing-remitting MS, specifically blocks T cell adhe-
sion, but not rolling, during EAE in vivo [10].
The spinal cord window described here is located at
the level of cervical spinal cord (C7-C5) and allows dir-
ect visualization of both the spinal cord leptomeningeal
and white matter microvessels under physiological con-
ditions [9]. During EAE, when inflammatory reactions
increase the depth of the leptomeningeal space on the
surface of the spinal cord, visualization of white matter
microvessels is limited due to the limitation of epifluor-
escence technique which has a tissue penetration of
50-70 μm. In contrast, the lumbar spinal cord window
usually employed for live cell imaging in the spinal cord
only allows for observation of the leptomeningeal blood
vessels, even when employing 2P-IVM with deeper
penetration into the tissue [6]. This might be due to the
differences in the angioarchitecture at the different levels
of the spinal cord.
The IVM approach introduced here can certainly be
extended to study the interaction of immune cell subsets
other than T cells with the spinal cord microvasculature
in vivo. Using the same experimental approach as
described for T cells we were able to show that immature
dendritic cells migrate into the CNS during EAE and use
α4-integrins to adhere to the inflamed spinal cord micro-
vasculature in vivo [28]. A critical prerequisite to study the
interaction of a given immune cell subset with the spinal
cord microvasculature using the IVM method described
here, is to obtain a highly purified population of the cells
of interest. This is due to the fact that only a limited num-
ber of cells infused into the systemic blood gain access to
the observation window of the spinal cord and even less
cells (about 10–20 fluorescent immune cells per field of
view (FOV) with 5–6 FOV per spinal cord window) are
expected to interact with the endothelium of the exposed
spinal cord window microvasculature.
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microvasculature during EAE we have therefore decided
to first investigate CD8+ T cells from a TCR transgenic
OT-I mouse. This allowed for a homogeneous
ovalbumin-specific T cell activation in vitro which
resulted in a population of activated CD8+ T cells with
more than 95% purity. Here we demonstrated that acti-
vated CD8+ T cells successfully interact with the
inflamed spinal cord microvessels during EAE. We
therefore asked whether α4-integrins, which are essential
for the migration of CD4+ T cells across the BBB, play
any role in the multi-step CD8+ T cell extravasation
across the BBB in vivo. Here we found that α4β7-, β7-
or α4-integrins are not required for the rolling and cap-
ture of CD8+ T to the inflamed spinal cord white matter
microvasculature. This is in accordance with our previ-
ous findings demonstrating that β1-integrin deficient
CD4+ and CD8+ T cells have no defect in capturing and
rolling on the inflamed BBB during EAE [25] and that
natalizumab fails to interfere with the rolling and captur-
ing of human T cells to the inflamed spinal cord micro-
vessels during EAE [10]. Interestingly, although we
initially saw a contribution of α4-integrins in mediating
the firm adhesion of CD8+ T cells to the inflamed spinal
cord microvasculature, this effect was lost mainly due to
the low number of firmly adhering CD8+ T cells
observed in the control group over time. These observa-
tions therefore suggest that stable adhesion of CD8+ T
cells to the inflamed BBB in vivo does not critically rely
on α4-integrins. Considering our previous observation
that β1-integrin deficient CD8+ T cells fail to enter the
CNS parenchyma during EAE [25], we propose that β1-
integrin mediated adhesions might be critical at a later
step, namely in CD8+ T cell crossing the endothelial
basement membrane.
Although the IVM approach described here allows for
live cell imaging of immune cell interactions with the
spinal cord microvasculature under physiological and
pathological conditions, some limitations apply due to
the fact that single-photon excitation used in conven-
tional epifluorescence video microscopy requires short
wavelength and therefore high energy excitation light.
This results in a disadvantageous high risk of phototoxi-
city and the restriction of imaging depth to 70 μm.
These limitations have been overcome by the introduc-
tion of two-photon IVM (2P-IVM) which enables deep
tissue penetration with less absorption or scattering of
fluorescent light than conventional IVM (for details see
[29]). 2P-IVM has a CNS tissue penetration of 800–
1000 μm [30]. It yields time-lapse videos with a high 3D
resolution allowing observation of immune cell interac-
tions with the spinal cord microvasculature over a long
time period. It is therefore suitable for observing the
slow post-arrest immune cell interactions with the spinalcord microvasculature such as T cell polarization, crawl-
ing and diapedesis taking place at velocities about
10 μm/min in vivo [6]. In contrast, 2P-IVM is not suited
to investigate the molecular mechanisms involved in the
fast initial T cell interaction steps with the BBB in vivo
taking place at velocities of about 40–100 μm/s.
In summary, combining state-of-the-art live cell im-
aging approaches with in vitro BBB models and sophisti-
cated surgical window preparations for in vivo
observation of the CNS microvasculature, provides a
powerful experimental approach to identify the molecu-
lar mechanisms employed by the BBB to control im-
mune cell trafficking into the CNS. The identification of
some of these traffic signals has proved to be of clinical
importance as blocking these molecules reduces the mi-
gration of pathogenic immune cells into the CNS and
proven beneficial for the treatment of MS. In contrast,
induction or enhancement of immune cell trafficking
signals on the BBB could be beneficial for the treatment
of CNS infections or neoplasia.Additional files
Additional file 1: Movie 1. Shear resistant arrest, polarization, crawling
and diapedesis of CD4+ T cells on and across TNF-α stimulated wt
pMBMECs under flow (low magnification). CD4+ T cells were perfused
over TNF-α stimulated pMBMECs under low shear (0.1 dyn/cm2) (upper
timer). After 4 min, flow was increased to physiological shear stress (1.5
dyne/cm2) (lower timer). The number of arrested CD4+ T cells constantly
increased during the accumulation phase. Physiological shear washed
away unbound T cells. Only few arrested CD4+ T cells detached from the
endothelial surface whereas the majority of CD4+ T cells either
continuously crawled or crawled and diapedesed through the
endothelium. Phase-contrast bright T cells crawl on the apical surface of
the endothelium, whereas phase-contrast dark T cells crawl beneath the
endothelium. Direction of flow is from left to right. Objective 10x
(Objective EC “Plan-Neofluar” 10x/0,3 Ph1 M27), phase-contrast
illumination at 12 images per min, recording time 19 min. Movie at 12
images per sec, field of view 653 μm x 869 μm.
Additional file 2: Movie 2. Shear-resistant arrest, polarization, crawling
and diapedesis of CD4+ T cells on and across TNF-α stimulated wt
pMBMECs under flow (high magnification). The experimental setup was
identical to that described in Movie 1. Images were taken with a 40x
objective (Objective LD “Plan-Neofluar” 40x/0,6 Korr Ph2 M27) under
differential interference contrast illumination at 3 images per min;
recording time 14.5 min. Movie at 8 images per sec; field of view
215 μm x 162 μm.
Additional file 3: Movie 3. Shear-resistant arrest, polarization, crawling
and diapedesis of CD4+ T cells on and across TNFα stimulated wt
pMBMECs under flow (high magnification). Movie corresponds to the
evaluation shown in Figure 2b. The experimental setup was identical to
that described in Movie 1. Flow increase to physiological shear stress (1.5
dyne/cm2) was at 8 min (lower timer). Numbers placed on T cells visible
on one frame of the movie (lower timer = 40 sec) were assigned for
identification of each individual T cell. Images were taken with a 20x
objective (Objective LD “Plan-Neofluar” 20x/0,4 Korr Ph2 M27) under
phase-contrast illumination at 3 images per min; recording time 21 min;
movie taken at 6 images per sec; field of view 438 μm x 329 μm.
Additional file 4: Movie 4. Initial contact of CD8+ T cells with the spinal
cord microvasculature during EAE. At the beginning, the inflamed spinal
cord microvasculature is visualized by TRITC-Dextran in the circulation of
a C57/BL6 mouse affected with EAE within one field of view (FOV) at x10
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above the large spinal cord collecting vein, always seen at the bottom of
each video frame. After switching the fluorescence filter on the
microscope, the infusion of 1 aliquot (1.3 x 106 cells/100μL) of CellTracker
green CD8+ T cells, pretreated for 20 min with rat IgG isotype control, is
started and T cells can be observed either passing through the
corresponding vascular beds or interacting as rolling or capturing to the
microvasculature in real time (objective x10) within one FOV.
Additional file 5: Movie 5. Firm adhesion of CD8+ T cells to the spinal
cord microvasculature during EAE. This movie first shows the entire spinal
cord window (x 4 objective) 10 minutes after infusion of the total
amount of CD8+ T cells (4 x 106 cells), then the scanning of several fields
of view within the entire spinal cord window to quantify those T cells
that firmly adhere to the inflamed spinal cord microvasculature (x 10
objective).
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